QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.47 (+0.71%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.88 (-0.93%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.26%)
GE   110.85 (+0.84%)
DIS   79.89 (-0.20%)
AMC   7.57 (-4.30%)
PFE   32.11 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
NASDAQ:LFCR

Lifecore Biomedical (LFCR) Stock Forecast, Price & News

$7.58
-0.34 (-4.29%)
(As of 09/27/2023 ET)
Compare
Today's Range
$7.53
$8.00
50-Day Range
$7.47
$10.84
52-Week Range
$1.52
$11.45
Volume
225,254 shs
Average Volume
579,380 shs
Market Capitalization
$229.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.50

Lifecore Biomedical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
25.3% Upside
$9.50 Price Target
Short Interest
Bearish
6.77% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.14mentions of Lifecore Biomedical in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.06) to $0.58 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.93 out of 5 stars

Medical Sector

708th out of 976 stocks

Pharmaceutical Preparations Industry

332nd out of 456 stocks


LFCR stock logo

About Lifecore Biomedical (NASDAQ:LFCR) Stock

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was incorporated in 1986 and is based in Chaska, Minnesota.

LFCR Price History

LFCR Stock News Headlines

Lifecore Biomedical (NASDAQ: LFCR)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Q4 2023 Lifecore Biomedical Inc Earnings Call
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Immatics (IMTX) Reports Q2 Loss, Tops Revenue Estimates
Lifecore Biomedical Inc.
See More Headlines
Receive LFCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lifecore Biomedical and its competitors with MarketBeat's FREE daily newsletter.

LFCR Company Calendar

Last Earnings
8/31/2023
Today
9/27/2023
Next Earnings (Estimated)
10/05/2023
Fiscal Year End
5/31/2024

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LFCR
Employees
689
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$9.50
High Stock Price Forecast
$10.00
Low Stock Price Forecast
$9.00
Forecasted Upside/Downside
+25.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-102,190,000.00
Pretax Margin
-59.59%

Debt

Sales & Book Value

Annual Sales
$103.27 million
Cash Flow
$3.93 per share
Book Value
$3.08 per share

Miscellaneous

Free Float
25,892,000
Market Cap
$229.83 million
Optionable
Optionable
Beta
1.13
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. James G. Hall (Age 60)
    CEO, Pres & Director
    Comp: $711.57k
  • Mr. John D. Morberg (Age 59)
    Exec. VP & CFO
    Comp: $443.43k
  • Dr. Albert D. Bolles Ph.D. (Age 65)
    Pres of Curation Foods, Inc.
    Comp: $688.19k
  • Mr. Steve W. Laninga
    VP of Operations
  • Dr. Kipling Thacker Ph.D. (Age 68)
    VP & Chief Scientist
  • Mr. Aaron Perlitsh
    Director of Internal Audit & Chief Compliance Officer
  • Mr. Darren M. Hieber
    Sr. VP of Corp. Devel. & Partnerships
  • Ms. Kara Morley
    Sr. VP of HR
  • Ms. Jackie Q. Klecker
    Exec. VP & GM
  • Mr. Matt Augustson
    Sr. VP of Information Technology













LFCR Stock - Frequently Asked Questions

Should I buy or sell Lifecore Biomedical stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Lifecore Biomedical in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" LFCR shares.
View LFCR analyst ratings
or view top-rated stocks.

What is Lifecore Biomedical's stock price forecast for 2023?

2 Wall Street analysts have issued 12 month target prices for Lifecore Biomedical's stock. Their LFCR share price forecasts range from $9.00 to $10.00. On average, they predict the company's stock price to reach $9.50 in the next twelve months. This suggests a possible upside of 25.3% from the stock's current price.
View analysts price targets for LFCR
or view top-rated stocks among Wall Street analysts.

How have LFCR shares performed in 2023?

Lifecore Biomedical's stock was trading at $6.48 at the beginning of 2023. Since then, LFCR shares have increased by 17.0% and is now trading at $7.58.
View the best growth stocks for 2023 here
.

Are investors shorting Lifecore Biomedical?

Lifecore Biomedical saw a increase in short interest in September. As of September 15th, there was short interest totaling 2,010,000 shares, an increase of 11.7% from the August 31st total of 1,800,000 shares. Based on an average daily volume of 266,900 shares, the short-interest ratio is currently 7.5 days. Approximately 6.8% of the shares of the stock are sold short.
View Lifecore Biomedical's Short Interest
.

When is Lifecore Biomedical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 5th 2023.
View our LFCR earnings forecast
.

How were Lifecore Biomedical's earnings last quarter?

Lifecore Biomedical, Inc. (NASDAQ:LFCR) issued its earnings results on Thursday, August, 31st. The company reported ($0.89) EPS for the quarter, missing analysts' consensus estimates of ($0.07) by $0.82. The company earned $31.55 million during the quarter, compared to analyst estimates of $28.99 million. Lifecore Biomedical had a negative trailing twelve-month return on equity of 79.34% and a negative net margin of 71.36%.

What is Lifecore Biomedical's stock symbol?

Lifecore Biomedical trades on the NASDAQ under the ticker symbol "LFCR."

Who are Lifecore Biomedical's major shareholders?

Lifecore Biomedical's stock is owned by a number of retail and institutional investors. Top institutional investors include Wynnefield Capital Inc. (16.24%), Cove Street Capital LLC (5.34%), BlackRock Inc. (1.75%), Visionary Wealth Advisors (1.65%), Geode Capital Management LLC (0.95%) and Royal Bank of Canada (0.48%).

How do I buy shares of Lifecore Biomedical?

Shares of LFCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Lifecore Biomedical's stock price today?

One share of LFCR stock can currently be purchased for approximately $7.58.

How much money does Lifecore Biomedical make?

Lifecore Biomedical (NASDAQ:LFCR) has a market capitalization of $229.83 million and generates $103.27 million in revenue each year. The company earns $-102,190,000.00 in net income (profit) each year or ($3.35) on an earnings per share basis.

How many employees does Lifecore Biomedical have?

The company employs 689 workers across the globe.

How can I contact Lifecore Biomedical?

Lifecore Biomedical's mailing address is 2811 AIRPARK DRIVE, SANTA MARIA CA, 93455. The official website for the company is www.lifecore.com. The company can be reached via phone at (800) 454-1355, via email at jeff.sonnek@icrinc.com, or via fax at 650-368-9818.

This page (NASDAQ:LFCR) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -